Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Rodyti

español (ES) (288.28 KB - PDF)

Rodyti

čeština (CS) (322.23 KB - PDF)

Rodyti

dansk (DA) (287.53 KB - PDF)

Rodyti

Deutsch (DE) (289.53 KB - PDF)

Rodyti

eesti (ET) (276.29 KB - PDF)

Rodyti

ελληνικά (EL) (335.21 KB - PDF)

Rodyti

français (FR) (289.25 KB - PDF)

Rodyti

hrvatski (HR) (307.68 KB - PDF)

Rodyti

latviešu (LV) (334.28 KB - PDF)

Rodyti

Malti (MT) (324.47 KB - PDF)

Rodyti

Nederlands (NL) (287.82 KB - PDF)

Rodyti

polski (PL) (380.69 KB - PDF)

Rodyti

português (PT) (288.12 KB - PDF)

Rodyti

română (RO) (482.45 KB - PDF)

Rodyti

slovenčina (SK) (324.97 KB - PDF)

Rodyti

slovenščina (SL) (318.42 KB - PDF)

Rodyti

suomi (FI) (285.73 KB - PDF)

Rodyti

svenska (SV) (287.15 KB - PDF)

Rodyti

Product information

български (BG) (936.84 KB - PDF)

Rodyti

español (ES) (457.64 KB - PDF)

Rodyti

čeština (CS) (695.23 KB - PDF)

Rodyti

dansk (DA) (443.55 KB - PDF)

Rodyti

Deutsch (DE) (456.17 KB - PDF)

Rodyti

eesti (ET) (460.88 KB - PDF)

Rodyti

ελληνικά (EL) (957.24 KB - PDF)

Rodyti

français (FR) (383.63 KB - PDF)

Rodyti

hrvatski (HR) (504.46 KB - PDF)

Rodyti

italiano (IT) (614.01 KB - PDF)

Rodyti

latviešu (LV) (750.12 KB - PDF)

Rodyti

lietuvių (LT) (673.01 KB - PDF)

Rodyti

magyar (HU) (1.07 MB - PDF)

Rodyti

Malti (MT) (774.79 KB - PDF)

Rodyti

Nederlands (NL) (445.92 KB - PDF)

Rodyti

polski (PL) (1.09 MB - PDF)

Rodyti

português (PT) (456.69 KB - PDF)

Rodyti

română (RO) (807.04 KB - PDF)

Rodyti

slovenčina (SK) (711.68 KB - PDF)

Rodyti

slovenščina (SL) (702.28 KB - PDF)

Rodyti

suomi (FI) (456.54 KB - PDF)

Rodyti

svenska (SV) (441.7 KB - PDF)

Rodyti

Íslenska (IS) (622.5 KB - PDF)

Rodyti

norsk (NO) (656.3 KB - PDF)

Rodyti
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Rodyti

español (ES) (219.22 KB - PDF)

Rodyti

čeština (CS) (262.67 KB - PDF)

Rodyti

dansk (DA) (227.42 KB - PDF)

Rodyti

Deutsch (DE) (218.75 KB - PDF)

Rodyti

eesti (ET) (221.16 KB - PDF)

Rodyti

ελληνικά (EL) (268.37 KB - PDF)

Rodyti

français (FR) (221.14 KB - PDF)

Rodyti

hrvatski (HR) (227.55 KB - PDF)

Rodyti

italiano (IT) (191.92 KB - PDF)

Rodyti

latviešu (LV) (256.74 KB - PDF)

Rodyti

lietuvių (LT) (210.34 KB - PDF)

Rodyti

magyar (HU) (210.45 KB - PDF)

Rodyti

Malti (MT) (250.85 KB - PDF)

Rodyti

Nederlands (NL) (228.06 KB - PDF)

Rodyti

polski (PL) (245.92 KB - PDF)

Rodyti

português (PT) (231.37 KB - PDF)

Rodyti

română (RO) (434.62 KB - PDF)

Rodyti

slovenčina (SK) (253.67 KB - PDF)

Rodyti

slovenščina (SL) (237.31 KB - PDF)

Rodyti

suomi (FI) (204.11 KB - PDF)

Rodyti

svenska (SV) (218.51 KB - PDF)

Rodyti

Íslenska (IS) (185.95 KB - PDF)

Rodyti

norsk (NO) (222.67 KB - PDF)

Rodyti

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page